NR4A1 and colorectal carcinoma: The treatment of hypoxic CRC cells with CK significantly blocks Nur77-mediated oncogenic signaling, leading to the suppression of CSC properties and metastases in vitro and in vivo with no apparent adverse effects, suggesting that CK could be a safe and effective therapeutic.